# Nano-X Imaging

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nano-x-imaging

- Industry: Medical Devices & Equipment
- Headquarters: Jerusalem, Israel
- Website: www.nanox.vision
- Total disclosed funding: $100M
- Latest round: Series B (Jul 28, 2020)
- Investors on record: 5

## About

Nano-X Imaging Ltd. specializes in advanced digital imaging solutions, utilizing innovative technology to enhance diagnostic capabilities in healthcare settings. Their proprietary systems aim to improve patient outcomes through accurate imaging and AI-driven analysis.Nano-X Imaging Ltd., founded in 2012, is based in Jerusalem, Israel. The company focuses on developing digital imaging systems and has undergone significant growth since its inception. CEO Erez Meltzer leads the company, which has completed 6 deals, with its most recent deal occurring on August 21, 2020. The company raised USD 193.22 mn in an IPO, which represents the total amount raised to date.Nanox primarily offers a digital multi-source 3D tomosynthesis imaging system, cleared by the FDA, which employs advanced radiographic visualization for improved diagnostic accuracy. This system utilizes a proprietary silicon-based, low-voltage technology to produce high-resolution images with reduced radiation doses. Additionally, Nanox.AI solutions leverage artificial intelligence to detect chronic diseases early, thereby enhancing preventative care. The company operates globally, focusing on regions with high disease rates, providing healthcare facilities with essential imaging technologies.In the most recent year, 2022, Nanox reported revenues of USD 8.58 mn, alongside an EBITDA of USD -104.80 mn. The company uses a B2B model, partnering with healthcare providers to deliver its imaging solutions, typically through structured agreements that include subscriptions for ongoing access to their systems and AI tools.Nano-X Imaging Ltd. plans to utilize the funds raised from the August 2020 IPO to support the global deployment of its imaging pipeline. The company is focused on expanding into new markets, targeting regions with a high prevalence of health challenges. They aim to introduce new products designed to further enhance diagnostic capabilities and efficiency for healthcare providers. Specific timelines for these expansions and product launches have not been disclosed.

## Funding rounds

- Series B, Jul 28, 2020, $54M — Industrial Alliance Insurance and Financial Services, SK Telecom Ventures, Foxconn Technology Group, Fujifilm Holdings Corporation, Yozma Group Korea
- Series B, Jun 4, 2020, $20M — SK Telecom Ventures
- Series B, Jan 16, 2020, $26M — SK Telecom Ventures, Foxconn Technology Group, Fujifilm Holdings Corporation

## Investors

- SK Telecom Ventures — Series B
- Foxconn Technology Group — Series B
- Fujifilm Holdings Corporation — Series B
- Industrial Alliance Insurance and Financial Services — Series B
- Yozma Group Korea (https://capitalatlas.ai/funds/yozma-group-korea) — Series B